Poor adherence to antihypertensive therapy is a major cause of poor blood pressure (BP)
control in patients with hypertension. Regimen simplification may improve adherence and …

Introduction There are positive aspects regarding the prescribing of fixed dose combinations
(FDCs) versus prescribing the medicines separately. However, these have to be balanced …

Objective: The 2018 European Society of Cardiology/European Society of Hypertension
Guidelines for the management of arterial hypertension raised the need for evidence to …

Medication adherence is a priority for health systems worldwide and is widely recognised as
a key component of quality of care for disease management. Adherence-related indicators …

Objectives Hypertension is a leading cause of death and disease burden followed by
dyslipidemia. Their asymptomatic nature leads to low adherence and persistence to …

Background: Uncontrolled blood pressure is a major risk factor for cardiovascular diseases.
Fixed-dose combination (FDC) therapy offers a promising approach to addressing this …

Objectives: This analysis compared adherence, cardiovascular (CV) events and all-cause
mortality incidence, and healthcare costs among hypertensive patients treated with …

Background Treatment guidelines for antiretroviral therapy (ART) have evolved to
emphasize newer regimens that address ageing-related comorbidities. Using national …

Hypertension and dyslipidemia are important risk factors for cardiovascular disease.
However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent …

Objective To evaluate the cost-effectiveness of a single-pill combination (SPC) of
perindopril/amlodipine/indapamide versus its free equivalent combination (FEC) in adults …